Did Halma & Marik highlight harms by the COVID spike protein due to virus AND COVID vaccine (mRNA technology based gene injection)? Yes!

SOURCE:

https://www.mdpi.com/2076-2607/11/5/1308#B12-microorganisms-11-01308

One significant mechanism of harm is vascular, and it is mediated by the spike protein, a common element of the COVID-19 illness, and it is related to receiving a COVID-19 vaccine. Given the significant number of people experiencing these two related conditions, it is imperative to develop treatment protocols, as well as to consider the diversity of people experiencing long COVID-19 and vaccine injury.

Biodistribution studies have found significant expression of spikes in other tissues and organs [12],

and researchers have found both vaccine mRNA and spike protein (which is encoded by the vaccine sequence) two months post-administration [14],

and even up to four months post-vaccination [13].

One preprint study of people with SARS-CoV-2 negative post-vaccination Long COVID-19-like symptoms showed spike protein persistence, on average, 105 days post vaccination [19].

Long COVID-19 patients (post SARS-CoV-2 infection) show spike protein persistence up to 15 months [20].

Another study showed spike protein persistence in the gut of long COVID-19 patients, but not in the bloodstream.

Spike proteins can be packaged in exosomes [13],

possibly resulting in inflammation and immune activation [21,22]

in organs and tissues distant from the injection site [13]. Extracellular vesicles are capable of crossing the blood–brain barrier [23],

and LNPs, as well as exosomes, will exchange more readily in small diameter vessels with low flow rates (i.e., capillaries and small vessels) [24]. Importantly, the spike protein seems to additionally impact blood–brain barrier permeability [25,26].’